Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    16717289 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Epidemiological EMESIS-Registry
Condition: Antiemetic Therapy
Intervention: Other: non-interventional
2 Enrolling by invitation Proof-of-Concept Trial of Palonosetron and Olanzapine Without Dexamethasone for the Prevention of CIN
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Olanzapine;   Drug: Palonosetron
3 Recruiting A Trial of TAS-114 in Combination With S-1
Condition: Advanced Solid Tumors
Interventions: Drug: TAS-114;   Drug: S-1

Study has passed its completion date and status has not been verified in more than two years.